AstraZeneca (AZN SS)

Analysis

Health Care • United Kingdom

AstraZeneca PLC is a Swedish-British multinational pharmaceutical and biotechnology company focused on the discovery, development, manufacture, and commercialization of prescription medicines. The company specializes in therapeutic areas including oncology, cardiovascular, renal and metabolism, respiratory and immunology, rare diseases, and vaccines. AstraZeneca was founded in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group PLC, and its headquarters are located in Cambridge, UK.

Refresh

Company Presentation • 08 Sep 2026 23:00

Investor update

Company Presentation • 27 Jul 2026 18:25

Q2 2026

Company Presentation • 06 Jul 2026 21:30

Investor update

Company Presentation • 09 Jun 2026 07:00

Investor update

Company Presentation • 01 Jun 2026 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00